124 related articles for article (PubMed ID: 31208420)
1. Effect of dipeptidyl-peptidase-4 inhibitors on C-reactive protein in patients with type 2 diabetes: a systematic review and meta-analysis.
Liu X; Men P; Wang B; Cai G; Zhao Z
Lipids Health Dis; 2019 Jun; 18(1):144. PubMed ID: 31208420
[TBL] [Abstract][Full Text] [Related]
2. Effect of DPP-4i inhibitors on renal function in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
Gong Y; Bai X; Zhang D; Yang X; Qin Z; Yang Y; Zhou Y; Meng J; Liu X
Lipids Health Dis; 2024 May; 23(1):157. PubMed ID: 38796440
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus.
Meng J; Yan R; Zhang C; Bai X; Yang X; Yang Y; Feng T; Liu X
Lipids Health Dis; 2023 Dec; 22(1):219. PubMed ID: 38082288
[TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis on the Association Between DPP-4 Inhibitors and Bone Mineral Density and Osteoporosis.
Huang L; Zhong W; Liang X; Wang H; Fu SE; Luo Z
J Clin Densitom; 2024; 27(1):101455. PubMed ID: 38101289
[TBL] [Abstract][Full Text] [Related]
5. Effect of dipeptidyl peptidase-4 inhibitor on the progression of coronary artery disease evaluated by computed tomography in patients receiving insulin therapy for type 2 diabetes mellitus.
Choi Y; Ko SH; Chang K; Yoo KD; Ihm SH
J Diabetes; 2023 Nov; 15(11):944-954. PubMed ID: 37528628
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of diabetes mellitus in bullous pemphigoid patients in the absence of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis.
Guo W; Rathi S; Marquez J; Smith H; Kuruvilla A; Tonnesen MG; Salvemini JN
Arch Dermatol Res; 2023 Oct; 315(8):2207-2213. PubMed ID: 36867222
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory activity of dipeptidyl peptidase-4 inhibitors in immune-related diseases.
Drakul M; Čolić M
Eur J Immunol; 2023 Dec; 53(12):e2250302. PubMed ID: 37732495
[TBL] [Abstract][Full Text] [Related]
8. Preventing CXCL12 elevation helps to reduce acute exacerbation of COPD in individuals co-existing type-2 diabetes: A bioinformatics and clinical pharmacology study.
Xue H; Chen Q; Lan X; Xu H; Yang H; Lin C; Xue Q; Xie B
Int Immunopharmacol; 2024 May; 132():111894. PubMed ID: 38569426
[TBL] [Abstract][Full Text] [Related]
9. Effects of Incretin-based Therapy on High-sensitivity C-reactive Protein in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Wu Y; Lu Y; Yang S; Zhang Q
Rev Invest Clin; 2020 Oct; 73(5):. PubMed ID: 33861731
[TBL] [Abstract][Full Text] [Related]
10. Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis.
Kan C; Zhang Y; Han F; Xu Q; Ye T; Hou N; Sun X
Front Endocrinol (Lausanne); 2021; 12():708494. PubMed ID: 34603199
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase-4 inhibitors and the risk of infection: A systematic review and meta-analysis of cardiovascular outcome trials.
Yang N; He LY; Liu P; Li ZY; Yang YC; Ping F; Xu LL; Li W; Zhang HB; Li YX
World J Diabetes; 2024 May; 15(5):1011-1020. PubMed ID: 38766432
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomised controlled trials.
Bray JJH; Foster-Davies H; Salem A; Hoole AL; Obaid DR; Halcox JPJ; Stephens JW
Diabetes Obes Metab; 2021 Aug; 23(8):1806-1822. PubMed ID: 33830637
[TBL] [Abstract][Full Text] [Related]
13. Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes.
Hartman ML; Sanyal AJ; Loomba R; Wilson JM; Nikooienejad A; Bray R; Karanikas CA; Duffin KL; Robins DA; Haupt A
Diabetes Care; 2020 Jun; 43(6):1352-1355. PubMed ID: 32291277
[TBL] [Abstract][Full Text] [Related]
14. Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effect of SGLT2 Inhibitor on Blood Leptin and Adiponectin Level in Patients with Type 2 Diabetes.
Wu P; Wen W; Li J; Xu J; Zhao M; Chen H; Sun J
Horm Metab Res; 2019 Aug; 51(8):487-494. PubMed ID: 31408894
[TBL] [Abstract][Full Text] [Related]
15. Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.
Anholm C; Kumarathurai P; Pedersen LR; Samkani A; Walzem RL; Nielsen OW; Kristiansen OP; Fenger M; Madsbad S; Sajadieh A; Haugaard SB
Atherosclerosis; 2019 Sep; 288():60-66. PubMed ID: 31326727
[TBL] [Abstract][Full Text] [Related]
16. GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer's Disease Therapy.
Złotek M; Kurowska A; Herbet M; Piątkowska-Chmiel I
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002034
[TBL] [Abstract][Full Text] [Related]
17. The Anti-Inflammatory Effect of Novel Antidiabetic Agents.
Theofilis P; Sagris M; Oikonomou E; Antonopoulos AS; Siasos G; Tsioufis K; Tousoulis D
Life (Basel); 2022 Nov; 12(11):. PubMed ID: 36362984
[TBL] [Abstract][Full Text] [Related]
18. [Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19].
Carrasco-Sánchez FJ; Carretero-Anibarro E; Gargallo MÁ; Gómez-Huelgas R; Merino-Torres JF; Orozco-Beltrán D; Pines Corrales PJ; Ruiz Quintero MA
Endocrinol Diabetes Nutr; 2022 Mar; 69(3):209-218. PubMed ID: 34778721
[TBL] [Abstract][Full Text] [Related]
19. Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus.
Wei X; Bai Y; Wang Z; Zheng X; Jin Z; Liu X
Diabetol Metab Syndr; 2021 Aug; 13(1):88. PubMed ID: 34446063
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis.
Dutta D; Agarwal A; Maisnam I; Singla R; Khandelwal D; Sharma M
Endocrinol Metab (Seoul); 2021 Apr; 36(2):374-387. PubMed ID: 33820392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
